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ABSTRACT
Histone deacetylase 6 (HDAC6), a predominantly cyto-
plasmic protein deacetylase, participates in a wide
range of cellular processes through its deacetylase
activity. However, the diverse functions of HDAC6 can-
not be fully elucidated with its known substrates. In an
attempt to explore the substrate diversity of HDAC6, we
performed quantitative proteomic analyses to monitor
changes in the abundance of protein lysine acetylation
in response to HDAC6 deﬁciency. We identiﬁed 107
proteins with elevated acetylation in the liver of HDAC6
knockout mice. Three cytoplasmic proteins, including
myosin heavy chain 9 (MYH9), heat shock cognate pro-
tein 70 (Hsc70), and dnaJ homolog subfamily A member
1 (DNAJA1), were veriﬁed to interact with HDAC6. The
acetylation levels of these proteins were negatively
regulated by HDAC6 both in the mouse liver and in
cultured cells. Functional studies reveal that HDAC6-
mediated deacetylation modulates the actin-binding
ability of MYH9 and the interaction between Hsc70 and
DNAJA1. These ﬁndings consolidate the notion that
HDAC6 serves as a critical regulator of protein
acetylation with the capability of coordinating various
cellular functions.
KEYWORDS HDAC6, substrate, lysine acetylation,
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INTRODUCTION
Reversible lysine acetylation, as an evolutionarily conserved
protein posttranslational modiﬁcation, regulates a variety of
cellular processes including gene expression, enzyme
activity, and protein-protein interactions. Although lysine
acetylation was initially reported to regulate nuclear proteins
such as histones and transcription factors (Allfrey et al.,
1964; Gershey et al., 1968; Gu and Roeder, 1997), large-
scale proteomic surveys have demonstrated that this modi-
ﬁcation is also prevalent outside the nucleus. The ﬁrst global
proteomic survey of reversible lysine acetylation described
37 acetylated proteins from the cytoplasmic fraction of HeLa
cells and 133 from the mitochondria of the mouse liver (Kim
et al., 2006). Subsequently, several groups reported a large
number of acetylated non-nuclear proteins (Choudhary et al.,
2009; Schwer et al., 2009; Zhao et al., 2010; Chen et al.,
2012). Recently, two studies have extensively characterized
the mitochondrial acetylome from the mouse liver via isotope
labeling-based or label-free proteomic quantiﬁcation (Hebert
et al., 2013; Rardin et al., 2013).
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In support of these proteomic surveys, several protein
acetyltransferases and deacetylases, key regulatory
enzymes of lysine acetylation, have been reported to localize
in the cytoplasm or in themitochondria (Peserico andSimone,
2011; Sadoul et al., 2011). In addition, many of these enzymes
undergo nucleocytoplasmic transport (Peserico and Simone,
2011; Sadoul et al., 2011). Histone deacetylase 6 (HDAC6), a
member of the class II HDAC family, is unique in being pre-
dominantly cytoplasmic (Verdel et al., 2000), which served as
an early indication of the vital roles of HDAC6 in regulating
lysine acetylation and relevant cellular pathways in the cyto-
plasm.Previous studies havedocumented several proteins as
the substrates of HDAC6, including α-tubulin (Hubbert et al.,
2002; Zhang et al., 2003), Hsp90 (Kovacs et al., 2005), cort-
actin (Zhang et al., 2007), peroxiredoxins (Parmigiani et al.,
2008), β-catenin (Li et al., 2008), Ku70 (Subramanian et al.,
2011), Tat (Huo et al., 2011), and survivin (Riolo et al., 2012).
Through the deacetylase activity, HDAC6 participates in a
wide range of cellular processes, such as cell motility (Hubbert
et al., 2002; Zhang et al., 2007; Li et al., 2011; Li et al., 2014),
cell proliferation (Li et al., 2008), and cell survival (Subrama-
nian et al., 2011; Riolo et al., 2012). The widespread roles of
HDAC6 are manifested in impaired immune response, bone
development, and glucocorticoid receptor translocation as
well as abnormal emotional behaviors observed in HDAC6
knockout mice (Zhang et al., 2008; Fukada et al., 2012).
However, thesephenotypescannot be fully elucidatedwith the
limited number of the known HDAC6 substrates. Thus, it
would be a plausible speculation that a set of uncharacterized
HDAC6 substrates are present in the cytoplasm. A global and
detailed analysis of the endogenous targets of HDAC6 will be
undoubtedly helpful to decipher its diverse functions.
In the present study, we report the ﬁrst quantitative pro-
teomic analysis of lysine-acetylated proteins in the cyto-
plasmic fraction of the mouse liver in response to HDAC6
deﬁciency. A simpliﬁed proteomic workﬂow combining pro-
tein immunopuriﬁcation, peptide isotope labeling, and 1D
LC-MS/MS analysis identiﬁed 107 proteins that were hy-
peracetylated in HDAC6 knockout mice. The subsequent
biochemical assays on selected substrates veriﬁed that
HDAC6 interacts with and deacetylates MYH9, Hsc70, and
DNAJA1. Moreover, our study implicates that HDAC6-med-
iated deacetylation plays pivotal roles in regulating the
functions of the new substrates. Therefore, our ﬁndings
expanded the knowledge on the HDAC6 substrate pool and
its functional diversity, which might be a valuable resource
for more in-depth dissection of HDAC6-mediated pathways
in the cytoplasm.
RESULTS
Strategy for lysine-acetylation proteomic analysis
of wild-type and HDAC6 knockout mice
To identify cytoplasmic proteins with acetylation levels
changed in response to HDAC6 deﬁciency, we prepared
cytoplasmic fractions from the liver tissues of wild-type and
HDAC6 knockout mice (Fig. 1A). Liver was chosen because
of the relatively high abundance and activity of HDAC6
observed in this tissue compared with others (Fig. S1A). The
protein extracts were then subjected to immunoprecipitation
with anti-acetyl-lysine antibodies. The enriched lysine-acet-
ylated proteins from wild-type and HDAC6 knockout mice
were subject to SDS-PAGE and concentrated into a single
gel band prior to tryptic digestion (Fig. 1A). Relative quanti-
ﬁcation of proteins from different samples was achieved by
dimethyl isotope labeling and MS according to previously
published methods (Boersema et al., 2008; Boersema et al.,
2009). Biological duplicates were prepared from two pairs of
wild-type and HDAC6 knockout littermates, with forward or
reverse isotope labeling. In each replicate, immunoprecipi-
tation and protein digestion were performed in triplicate given
that most experimental variation was introduced in these
steps.
It is noteworthy that our workﬂow simpliﬁes the proteomic
analysis by targeting a limited number of lysine-acetylated
proteins in the cytoplasm so that 1D LC-MS/MS is adequate
for protein identiﬁcation and quantiﬁcation. It is recognized,
however, that our workﬂow is unable to pinpoint the acety-
lation sites or directly measure changes of modiﬁed peptides
in the acetylated proteins. Enzyme-mediated modiﬁcation
sites on numerous substrates could be revealed by large-
scale proteomic analysis of enriched peptides. This peptide-
centric strategy typically requires subcellular fractionation
and 2D LC-MS/MS analysis, which were employed in the
previous elegant studies of sirtuin 1 (SIRT1), SIRT3, and
SIRT5 (Chen et al., 2012; Hebert et al., 2013; Park et al.,
2013; Rardin et al., 2013). By adopting a less time-con-
suming proteomic workﬂow, we attempted to expedite our
discovery phase and devote more effort to the downstream
substrate validation and functional studies.
Plentiful cytoplasmic proteins are hyperacetylated
in HDAC6 knockout mice
Anti-acetyl-lysine immunoprecipitates prepared from the
cytoplasmic extracts of the HDAC6 knockout mouse liver
showed more abundant acetylation over a wide array of
proteins than the wild-type tissue (Fig. 1B). To examine
whether the above effect is due to HDAC6 deﬁciency-
induced down-regulation of other deacetylase family mem-
bers, such as HDAC3, HDAC4, HDAC5, HDAC7, HDAC9,
HDAC11, and SIRT2, we performed immunoblotting to
compare the expression of these deacetylases in wild-type
and HDAC6 knockout mouse liver tissues. We found that
HDAC6 deﬁciency did not signiﬁcantly affect the expression
of these deacetylases in the mouse liver (Fig. S1B). These
data indicate that HDAC6 is an important regulator of lysine
acetylation in the cytoplasm.
From the six replicates of proteomic analysis, 303 high-
conﬁdence proteins were quantiﬁed in at least four
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replicates. Their knockout/wild-type ratios indicate relative
changes of protein acetylation levels in the livers of HDAC6
knockout mice vs. wild-type mice. Statistical tests were
performed to identify signiﬁcantly changed lysine-acetylated
proteins in response to HDAC6 deﬁciency (P < 0.01, over
1.5-fold change, Datasheet S1). The initial proteomic iden-
tiﬁcation and quantiﬁcation reports for all six replicates were
provided in Datasheet S2. Cellular compartment analysis of
the conﬁdently quantiﬁed proteins in our study suggested the
enrichment of large portion of cytoplasmic (68%) and mito-
chondrial (25%) proteins with the anti-acetyl-lysine antibod-
ies (Fig. 1C). As a result of nuclear depletion, the fraction of
nuclear proteins in our dataset (15%) was signiﬁcantly lower





















































































































Figure 1. Experimental strategy for the identiﬁcation of HDAC6-regulated acetylated proteins in mouse liver tissues.
(A) Schematic of the experimental workﬂow. Cytoplasmic proteins extracted from the liver tissues of wild-type and HDAC6 knockout
mice were subjected to immunopuriﬁcation, SDS-PAGE, in-gel digestion, and isotope labeling followed by 1D LC-MS/MS analysis.
(B) Coomassie blue-stained SDS-PAGE of cytoplasmic protein extracts prior to (left panel) or post (right panel) immunopuriﬁcation
with an antibody against acetylated lysine (AcK). (C) Cellular compartment distribution of 303 quantiﬁed proteins in our dataset.
(D) Overlap of lysine-acetylated protein identiﬁcation between our dataset (in color) and a large MEF acetylome dataset reported by
the Zhao’s group (Chen et al., 2012) (grey). The fraction of potential HDAC6 substrates (yellow) is entailed in the total of quantiﬁed
proteins in our study (pink). (E) Scatter plot showing the relative quantiﬁcation of lysine-acetylated proteins in relation to signiﬁcance
of the protein ratio. Red and green dots represent proteins with increased or decreased acetylation abundance in HDAC6 knockout
vs. wild-type mice, respectively. Black dots represent proteins with no signiﬁcant changes in acetylation levels. (F) Representative
biological processes and molecular functions signiﬁcantly enriched in proteins with altered acetylation levels in HDAC6 knockout vs.
wild-type mice, suggested by ontology annotation.
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of SIRT1 knockout MEFs (28% nuclear proteins) (Chen
et al., 2012). This previous analysis of SIRT1 knockout
MEFs represents one of the highest numbers of acetylated
proteins and acetylated sites reported in mammals. Although
our dataset was relatively small and only included quantiﬁ-
able proteins selected with stringent criteria, 187 proteins
from our analysis did not overlap with the ∼1800 acetylated
proteins reported earlier (Fig. 1D).
In addition, we compared our protein identiﬁcations with
two latest acetylome analyses of mitochondrial proteins from
the liver of SIRT3 knockout mice (Hebert et al., 2013; Rardin
et al., 2013) and also found unique proteins in our dataset
(Fig. S2). Differences in sample source, protein extraction
and fractionation, antibody enrichment strategy (protein vs.
peptide), LC separation (1D vs. 2D), and MS platform could
all result in differences in protein identiﬁcation. Therefore,
our study made a distinct contribution to the acetyl proteomic
atlas of the mouse liver, and more importantly, uncovered a
subset of acetylated proteins potentially regulated by
HDAC6.
Out of the 303 high-conﬁdence proteins, 107 proteins
showed increased acetylation abundance in HDAC6
knockout mice and 27 proteins were decreased in acetyla-
tion levels (Fig. 1E). Known substrates of HDAC6, such as
α-tubulin isoforms and peroxiredoxin, were found in the up-
regulated subset with a fold-change of 1.6 up to 9.1
(P < 0.01). HDAC6 deﬁciency dramatically increased the
acetylation level of a number of cytoplasmic and mitochon-
drial proteins which are regarded as the potential new sub-
strates of this deacetylase (Fig. 1E; Datasheet S1). These
proteins with molecular functions of nucleotide/cofactor/
vitamin binding or GTPase/ATPase activity are signiﬁcantly
enriched in processes related to microtubule-based move-
ment, carboxylic acid catabolism, and oxidative stress
response as well as RNA processing (enrichment P < 0.01),
suggesting the large substrate diversity of HDAC6 (Fig. 1F).
HDAC6 deacetylates selected substrate candidates
As we were interested in the discovery of new cytoplasmic
substrates, we excluded all known HDAC6 substrates such
as tubulin and peroxiredoxin I (Prx I) and mitochondrial
enzymes such as Dlst and Adhfe1 that were co-puriﬁed in
the immunoprecipitation step. We selected three cytoplasmic
proteins with 1.8 to 4.4-fold increase of the acetylation level
in response to HDAC6 deﬁciency as potential new sub-
strates of HDAC6, including MYH9, Hsc70, and DNAJA1,
which have been previously reported to undergo reversible
lysine acetylation (Choudhary et al., 2009).
Multiple biochemical assays were employed for substrate
validation. Immunoprecipitation was ﬁrst performed on liver
protein extracts of wild-type and HDAC6 knockout mice with
anti-acetyl-lysine antibodies followed by immunoblot ana-
lysis of individual proteins (forward validation). Akin to sev-
eral known HDAC6 substrates such as α-tubulin, Hsp90, and
Prx I, MYH9, Hsc70, and DNAJA1 were immunoprecipitated
by the anti-acetyl-lysine antibody in higher amount from
HDAC6 knockout mice than wild-type mice (Fig. 2A), sug-
gesting that their acetylation abundance was elevated upon
HDAC6 deﬁciency. In the reciprocal experiment, liver
extracts were immunoprecipitated with antibodies against
individual putative substrates, followed by detection of their
acetylation abundance (reverse validation). MYH9 and
DNAJA1 from HDAC6 knockout mouse liver showed
increased acetylation signal when compared with those from
the wild-type tissue (Fig. 2B), whereas acetylated Hsc70 was
undetectable in the reverse validation experiment.
Mouse embryonic ﬁbroblasts (MEFs) generated from
wild-type and HDAC6 knockout mice were used for further
veriﬁcation. By the forward validation method using total cell
lysates, we observed elevated acetylation abundance of
MYH9, Hsc70, and DNAJA1 from HDAC6 knockout MEFs
(Fig. 2C).
To assess whether the deacetylation of the substrate
candidates is dependent on HDAC6 activity, we treated 293T
cells with the HDAC6-speciﬁc inhibitor tubacin (Haggarty
et al., 2003) before analyzing the changes in substrate
acetylation level. The efﬁciency of drug treatment was
demonstrated by effective inhibition of α-tubulin deacetyla-
tion by HDAC6 (Fig. S3A). Results of forward and reverse
validation showed that tubacin treatment resulted in elevated
acetylation abundance of all three substrate candidates in
293T cells (Fig. 2D–F). Treatment of cells with trichostatin A
(TSA), an inhibitor of the class I and II HDACs (Yoshida
et al., 1995), also increased the acetylation levels of the
putative substrates in a dose-dependent manner, whereas
treatment with sodium butyrate (NaB), an HDAC inhibitor not
affecting HDAC6 (Barlow et al., 2001), led to no change in
the acetylation of MYH9 or Hsc70 (Fig. S3B and S3C).
These data strongly suggest that HDAC6 is the major, if not
the only, regulator of acetylation of these three substrate
candidates.
Given that the proteomic identiﬁcation of the three sub-
strate candidates was from the cytoplasmic fractions of
mouse liver tissues, we further performed the experimental
validations with cytoplasmic fractions of 293T cells. As
shown in Fig. 2G, all the three substrate candidates showed
elevated acetylation in response to tubacin treatment. We
also found that overexpression of GFP-HDAC6 signiﬁcantly
decreased the acetylation levels of MYH9, Hsc70, and
DNAJA1 (Fig. 2H). Taken together, our multi-facet validation
assays using the mouse liver, MEFs, and cell lines demon-
strate that HDAC6 deacetylates the three new substrates.
HDAC6 interacts with the new substrates
Given that physical interactions are required for enzyme-
substrate pairs as reported for HDAC6 and its known sub-
strates (Hubbert et al., 2002; Zhang et al., 2003; Kovacs
et al., 2005; Zhang et al., 2007), we examined by immuno-
precipitation and immunoﬂuorescence microscopy whether
HDAC6 interacts with the new substrates. As shown in
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Fig. 3A, endogenous MYH9, Hsc70, and DNAJA1 were
present in the immunoprecipitates of endogenous HDAC6 in
293T cells.
To further characterize the interaction of HDAC6 with the
novel substrates, a series of transfection and immunopre-
cipitation were performed. The anti-GFP antibodies speciﬁ-
cally coprecipitated MYH9 (Fig. 3B), Hsc70 (Fig. 3C), and
DNAJA1 (Fig. 3D) from 293T cells transfected with GFP-
HDAC6 but not GFP alone. Collectively, these data suggest
that both endogenous and exogenously expressed HDAC6
interact with the new substrates.
Next, we examined the subcellular localization of HDAC6
and the new substrates by immunoﬂuorescence confocal
microscopy. A fraction of MYH9 diffusely present in the
cytoplasm of HeLa cells showed signiﬁcant colocalization


































































































Figure 2. HDAC6 deacetylates selected substrate candidates. (A) Soluble cytoplasmic proteins were extracted from the liver
tissues of wild-type and HDAC6 knockout mice, and immunoprecipitation was performed with anti-AcK antibodies. The
immunoprecipitates and tissue extracts were then immunoblotted with the indicated antibodies. (B) Protein samples were prepared
as in (A), and immunoprecipitation was performed with anti-MYH9 or anti-DNAJA1 antibodies. The immunoprecipitates and tissue
extracts were then immunoblotted with the indicated antibodies. (C) Total cell lysates were prepared from wild-type and HDAC6
knockout MEFs. Anti-AcK immunoprecipitates and cell lysates were immunoblotted with antibodies against MYH9, Hsc70, or
DNAJA1. (D–F) 293T cells were treated with DMSO (−) or tubacin (+) for 8 h. Anti-AcK, anti-MYH9, anti-Hsc70, or anti-DNAJA1
immunoprecipitates and total cell lysates were immunoblotted with the indicated antibodies. (G) Cytoplasmic proteins were extracted
from 293T cells treated with DMSO (−) or tubacin (+) for 8 h. Anti-AcK immunoprecipitates and cytoplasmic extracts were
immunoblotted with antibodies against MYH9, Hsc70, or DNAJA1. (H) 293T cells were transfected with GFP-HDAC6 or GFP alone.
Immunoprecipitation and immunoblotting were then performed with the indicated antibodies.
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to the actin ﬁlaments, barely colocalized with HDAC6
(Fig. 3E). Hsc70 resided predominantly in the cytoplasm and
showed apparent colocalization with HDAC6 (Fig. 3F).
DNAJA1 diffusely distributed both in the nucleus and in the
cytoplasm and partially colocalized with HDAC6 in the
cytoplasm (Fig. 3G). Together, these results demonstrate
that HDAC6 interacts with the three new substrates and
colocalizes with each substrate to a certain level.
HDAC6-mediated deacetylation of MYH9
downregulates its actin-binding activity
MYH9 is known to associate with actin ﬁlaments through its
globular head domain (Sutoh, 1982). We thus investigated
whether the deacetylation of MYH9 by HDAC6 affects its
actin-binding ability. Immunoprecipitation assay revealed
that MYH9 interacted more strongly with actin in HDAC6
knockout MEFs as compared to wild-type MEFs (Fig. 4A).
In addition, HDAC6 knockout MEFs exhibited stronger
colocalization between MYH9 and actin, especially near the
cell periphery (Fig. 4B). By immunoprecipitation assays, we
further found that the actin-binding ability of MYH9 was
increased by treatment with tubacin and TSA, but not NaB
(Fig. 4C and 4D). Tubacin also led to signiﬁcantly
enhanced colocalization of MYH9 and actin, particularly
near the cell periphery and the cell-cell junctions (Fig. 4E).
Furthermore, overexpression of GFP-HDAC6 markedly
attenuated the actin-binding afﬁnity of MYH9 (Fig. 4F).
Collectively, these results demonstrate that HDAC6-medi-
ated deacetylation of MYH9 downregulates its actin-binding
activity.
HDAC6-mediated deacetylation of Hsc70
and DNAJA1 are critical for their interaction
Hsc70 and DNAJA1 are known to function together to pro-
mote proper folding of proteins (Meacham et al., 1999). Our
ﬁndings that HDAC6 deacetylates both Hsc70 and DNAJA1
prompted us to determine whether the association between
these two proteins is inﬂuenced by HDAC6. By immuno-
precipitation assays, we found that the interaction between
Hsc70 and DNAJA1 was signiﬁcantly decreased in HDAC6
knockout MEFs as compared to wild-type MEFs (Fig. 5A and
5B). In addition, treatment of cells with the HDAC6 inhibitor
tubacin remarkably inhibited the interaction between these
two proteins (Fig. 5C and 5D). Furthermore, overexpression
of wild-type HDAC6, but not the catalytically inactive mutant
that harbors H216A and H611A mutations (Grozinger et al.,
1999), enhanced the interaction between Hsc70 and
DNAJA1 (Fig. 5E and 5F). These data suggest that HDAC6-
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Figure 3. HDAC6 interacts with the new substrates. (A) 293T cell lysates were incubated with control IgG or anti-HDAC6
antibodies. The immunoprecipitates and cell lysates were then immunoblotted with the indicated antibodies. (B–D) 293T cells were
transfected with GFP-HDAC6 or GFP alone. Anti-GFP immunoprecipitates and cell lysates were immunoblotted with the indicated
antibodies. (E–G) Immunoﬂuorescence confocal images of HeLa cells transfected with GFP-HDAC6 and stained with anti-MYH9 (E),
anti-Hsc70 (F), or anti-DNAJA1 (G) antibodies and the DNA dye DAPI.
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Detection of cytoplasmic HDAC6 substrates is often hin-
dered by the high abundance of heavily acetylated histones
and other proteins in the nucleus or mitochondria, and pos-
sibly low abundance of certain acetylated proteins in the
cytoplasm. In this study, we attempted to circumvent these
technical issues by combining subcellular fractionation,
afﬁnity puriﬁcation, and high-resolution and high-accuracy
mass spectrometry to speciﬁcally enrich and quantify acet-
ylated proteins from the cytoplasmic fraction of the mouse
liver.
Prior to our study, a handful of proteins were well char-
acterized to be HDAC6 substrates, such as α-tubulin (Hub-
bert et al., 2002; Zhang et al., 2003), Hsp90 (Kovacs et al.,
2005), and peroxiredoxins (Parmigiani et al., 2008). Our
quantitative proteomic analysis conﬁrmed the hyperacetyla-
tion of these known substrates in HDAC6 knockout mice and
further uncovered more proteins with increased acetylation
in response to HDAC6 deﬁciency. Notably, a few other
known substrates including cortactin (Zhang et al., 2007),
survivin (Riolo et al., 2012), β-catenin (Li et al., 2008), and

















































Figure 4. HDAC6-mediated deacetylation of MYH9 downregulates its actin-binding activity. (A) Lysates from wild-type and
HDAC6 knockout MEFs were immunoprecipitated with anti-MYH9 antibodies. The immunoprecipitates and cell lysates were
subjected to immunoblotting with anti-β-actin or anti-MYH9 antibodies. (B) Immunoﬂuorescence images of wild-type and HDAC6
knockout MEFs stained with the anti-MYH9 antibody, phalloidin, and DAPI. (C) 293Tcells were treated with tubacin, TSA, or NaB for
8 h. Anti-MYH9 immunoprecipitates and cell lysates were immunoblotted with anti-β-actin or anti-MYH9 antibodies. (D) 293T cells
were treated with tubacin or TSA (1 or 5 μmol/L) and examined as in (C). (E) Immunoﬂuorescence images of HeLa cells treated with
DMSO or tubacin and stained with the anti-MYH9 antibody, phalloidin, and DAPI. (F) 293Tcells were transfected with GFP-HDAC6 or
GFP alone. Anti-MYH9 immunoprecipitates and cell lysates were immunoblotted with the indicated antibodies.
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study, possibly due to the low efﬁciency of the anti-acetyl-
lysine antibodies in enriching these particular proteins. In
addition, the predominant nuclear localization of survivin in
response to HDAC6 deﬁciency (Riolo et al., 2012), the
dependence on epidermal growth factor-stimulation of
β-catenin deacetylation by HDAC6 (Li et al., 2008), and the
variable expression levels of Ku70 in different cells and tis-
sues, could collectively contribute to the difﬁculties in iden-
tifying these known substrates. An alternative workﬂow
involving the enrichment of acetylated peptides coupled with
extensive 2D-LC separation might render a more in-depth
characterization of HDAC6-mediated acetylome dynamics.
HDAC6-mediated deacetylation of α-tubulin has been
reported to regulate microtubule-dependent cell motility
(Hubbert et al., 2002; Tran et al., 2007). In addition, actin-
based cell movement has been demonstrated to be modu-
lated by HDAC6 via deacetylation of the actin-binding protein
cortactin (Zhang et al., 2007). In this report, we demonstrate
that HDAC6 deacetylates MYH9, another actin-binding pro-
tein that is part of non-muscle myosin IIA (NM IIA), and
thereby negatively regulates the actin-binding afﬁnity of
MYH9 in cells (Fig. 6). Through the regulation of the actin
cytoskeleton, NM IIA is known to modulate various cellular
processes such as cell migration, cell adhesion, and cell
polarity, in ATPase activity-dependent or -independent
manners (Vicente-Manzanares et al., 2009). The ATPase
activity of NM IIA is activated when MYH9 binds to actin
through the globular head domain, and is further regulated
by reversible phosphorylation of the regulatory light chain























































Figure 5. HDAC6-mediated deacetylation of Hsc70 and DNAJA1 are critical for their interaction. (A and B) Lysates from wild-
type and HDAC6 knockout MEFs were immunoprecipitated with anti-Hsc70 (A) or anti-DNAJA1 (B) antibodies. The immunopre-
cipitates and cell lysates were then subjected to immunoblotting with anti-DNAJA1 or anti-Hsc70 antibodies. (C and D) 293T cells
were treated with DMSO (−) or tubacin (+) for 8 h, and the lysates were immunoprecipitated with anti-Hsc70 (C) or anti-DNAJA1
(D) antibodies. The immunoprecipitates and cell lysates were then immunoblotted with anti-DNAJA1 or anti-Hsc70 antibodies. (E and
F) 293Tcells were transfected with GFP-HDAC6 wild-type (WT), the catalytically inactive mutant (MT), or GFP alone, and the lysates
were immunoprecipitated with anti-Hsc70 (E) or anti-DNAJA1 (F) antibodies. The immunoprecipitates and cell lysates were then
immunoblotted with anti-DNAJA1, anti-Hsc70, or anti-GFP antibodies.
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phosphorylation has been shown to have little or no effect on
the actin-binding afﬁnity of MYH9 (Sellers et al., 1982).
Interestingly, our ﬁndings indicate that the actin-binding
activity of MYH9 is altered in response to its acetylation
status, which may further inﬂuence the ATPase activity of
NM IIA, at least at the initial activation stage. NM IIA has
been shown previously to be essential for the formation and
stability of the cell-cell junctions (Vicente-Manzanares et al.,
2009). Intriguingly, our data show that inhibition of HDAC6
activity induces intensive distribution of MYH9 to the cell-cell
junctions. This might provide an additional explanation for
the inhibitory effects of HDAC6 inhibitors on cell movement.
It has been shown previously that Hsp90 hyperacetyla-
tion, resulting from HDAC6 inhibition, leads to the dissocia-
tion of Hsp90 from its co-chaperone p23 and the loss of the
chaperone activity of Hsp90 (Kovacs et al., 2005). Likewise,
in this study we show that HDAC6 deacetylates Hsc70,
another chaperone protein, and its co-chaperone DNAJA1,
and inﬂuences the interaction between Hsc70 and DNAJA1
(Fig. 6). Due to the lack of knowledge about the sites of
Hsc70 and DNAJA1 modulated by HDAC6, although we
speculate that the effect of HDAC6 on the Hsc70-DNAJA1
interaction might be attributed to HDAC6-mediated deacet-
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Figure 6. Proposed model for HDAC6-mediated deacetylation and regulation of new substrates. (I) HDAC6 deacetylates
MYH9 and inhibits its actin-binding activity. (II) HDAC6 deacetylates Hsc70 and DNAJA1 and enhances their interaction, which might
further modulate their function as a chaperone pair.
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role in regulating their interaction. It has been well deﬁned
that the binding of the co-chaperone to Hsc70 stimulates its
ATPase activity (Bukau and Horwich, 1998), it is thus con-
ceivable that HDAC6 plays a crucial role in modulating the
functions of the DNAJA1/Hsc70 chaperone pair. Our results,
together with previous ﬁndings, therefore strongly suggest
that HDAC6 is a critical regulator of the chaperone network.
In conclusion, our study has identiﬁed three new substrates
of HDAC6 in the cytoplasm and provided a resource of putative
cytoplasmic targets of this deacetylase for further investigation.
The wide substrate diversity of HDAC6 suggests that it may
play profound roles in multiple interrelated processes and
pathways in the cytoplasm. Considering that small molecule
compounds targeting HDACs are currently undergoing clinical
trials for the treatment of cancer and metabolic diseases, a
better understanding of HDAC6-dependent cellular processes
would be highly valuable for the evaluation of the clinical rele-
vance and therapeutic efﬁcacy of HDAC6 inhibitors.
MATERIALS AND METHODS
Plasmids, chemicals, and antibodies
The GFP-HDAC6 expression plasmid was constructed by cloning
human HDAC6 cDNA into the pEGFPN1 vector, and the catalytically
inactive mutant was generated by site-directed mutagenesis as
described (Zhou et al., 2009; Li et al., 2014). Triethylammonium bicar-
bonate, formaldehyde-H2 (28% in H2O), sodium cyanoborohydride,
ammonium hydroxide, triﬂuoroacetic acid, 4’,6-diamidino-2-phenylin-
dole (DAPI), ﬂuorescein-phalloidin, trichostatin A (TSA), and sodium
butyrate (NaB) were purchased fromSigma-Aldrich. Formaldehyde-D2
(28% in D2O, Cambridge Isotope Laboratory), formic acid and aceto-
nitrile (Merck), andC18 desaltingmicrocolumns (NestGroup)were from
the indicatedsources.Tubacinwasobtained fromStuartSchreiber (Har-
vard Medical School). Antibodies against α-tubulin, acetylated
α-tubulin, and β-actin (Sigma-Aldrich), HDAC6, HDAC7, HDAC9,
Hsp90, Prx I, MYH9, Hsc70, and DNAJA1 (Abcam), HDAC3, HDAC4,
HDAC5,HDAC11, andSIRT2 (SantaCruzBiotechnology), acetylated
lysine (Cell Signaling Technology), and GFP (Roche), horseradish
peroxidase-conjugated secondary antibodies (AmershamBiosciences),
and rhodamine-conjugated secondary antibodies (Jackson Immuno-
Research Laboratories) were obtained from the indicated sources.
Mice and cells
HDAC6 knockout mice (in 129/C57BL6 mixed genetic background)
were generated and genotyped as described previously (Gao et al.,
2007). HDAC6 heterozygous mice were intercrossed to generate
wild-type and HDAC6 knockout littermates. Mouse embryonic
ﬁbroblasts (MEFs) were isolated and cultured as previously descri-
bed (Gao et al., 2007). HeLa and 293T cells were cultured in DMEM
medium supplemented with 10% fetal bovine serum at 37°C in a
humidiﬁed atmosphere with 5% CO2. All mouse experiments were
performed in accordance with the relevant institutional and national
guidelines and regulations; the experiments were approved by the
Animal Care and Use Committee of Nankai University, and all
experiments conform to the relevant regulatory standards.
Cytoplasmic protein extraction from the mouse liver
Mouse liver tissues were minced into small pieces with a razor blade
and scissors, and transferred to a glass Dounce homogenizer. The
minced tissues were suspended in ice-cold PBS (pH 7.5) supple-
mented with the protease inhibitor cocktail (Roche) and homoge-
nized with 40 strokes on ice. The homogenized mixture was
centrifuged at 1000 ×g at 4°C for 10 min. The supernatant was
transferred to another centrifuge tube and subjected to further cen-
trifugation at 10,000 ×g at 4°C for 30 min. The supernatant was
collected as the cytoplasmic fraction and used for subsequent
analysis. Biological replicates were obtained from two pairs of wild-
type and HDAC6 knockout littermates.
Afﬁnity enrichment and in-gel tryptic digestion of lysine-acet-
ylated proteins
For afﬁnity enrichment of lysine-acetylated proteins, the cytoplasmic
fractions isolated from mouse liver tissues were incubated with anti-
acetyl-lysine agarose beads at 4°C for 12 h with gentle shaking. The
supernatant was removed and the beads were washed ﬁve times
with ice-cold PBS (pH 7.5). The bound proteins were eluted from the
beads with 2% SDS in 50 mmol/L Tris-HCl buffer (pH 8.0) by boiling
for 10 min. The eluted fractions were dried in a vacuum evaporator.
The resulting proteins from the afﬁnity enrichment were loaded onto
SDS-PAGE and concentrated at the boundary between the stacking
gel and the separation gel. The single protein band of each sample
stained by Coomassie blue was excised from the gel, and subjected
to standard in-gel tryptic digestion as previously described (Shev-
chenko et al., 2006). The extracted peptide solutions were evapo-
rated in a vacuum evaporator prior to stable isotope labeling. For
each biological replicate of protein extracts from wild-type and
HDAC6 knockout mouse livers, afﬁnity enrichment and protein
digestion were performed in triplicate.
Stable isotope dimethyl labeling
Tryptic peptides from each sample were redissolved in 100 mmol/L
triethylammonium bicarbonate (pH 8.5). Subsequently, for light
labeling, 4 µL of formaldehyde-H2 (4% in water) was added to the
solution (1:25 v/v) and vortexed for 1 min, followed by the addition of
freshly prepared sodium cyanoborohydride to reach a ﬁnal con-
centration of 25 mmol/L. The resultant mixture was incubated with
shaking for 1 h at room temperature. A total of 16 µL of ammonia
(1%) was added to consume the excess formaldehyde. Finally, 8 µL
of formic acid (5%) was added to acidify the solution. For heavy
labeling, 4 µL of formaldehyde-D2 (4% in D2O) was added. The light
and heavy dimethyl-labeled peptides derived from equal amount of
wild-type and HDAC6 knockout mouse liver protein extracts were
pooled and desalted using C18 microcolumns. Forward and reverse
labeling was performed separately for independent biological
replicates.
Nano-HPLC-MS/MS analysis
The mixed isotope-labeled peptides were analyzed by nanoﬂow
reverse-phase UPLC-ESI-MS/MS using an Eksigent Ultra Plus
nano-HPLC (AB SCIEX) connected to a quadrupole time-of-ﬂight
(QqTOF) TripleTOF 5600 mass spectrometer (AB SCIEX). After
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injection, peptide mixtures were transferred onto the analytical col-
umn (C18 Acclaim PepMap100, 75 µm I.D. × 15 cm, 3 µm particle
size, Dionex) and eluted with a gradient of 2% to 35% B (A: 2%
acetonitrile/98% water/0.1% formic acid; B: 98% acetonitrile/2%
water/0.1% formic acid) over 1 h. Mass spectra and tandem mass
spectra were recorded in positive-ion and “high-sensitivity” mode
(resolution ∼35,000). The mass window for precursor ion selection
was set to ± 1 m/z. Advanced information dependent acquisition
(IDA) was employed for MS/MS collection of the 20 most abundant
parent ions. The exclusion mass width was 50 mDa and the exclu-
sion duration was 20 s.
Proteomic data analysis
Data were processed with Protein Pilot Software v.4.0 (AB SCIEX)
utilizing the Paragon and Progroup Algorithm (Shilov et al., 2007).
The software performs automatic recalibration such that typical
mass errors for MS and MS/MS data were below 10 ppm. The
database employed was an IPI mouse protein database (version
3.87) supplemented with the trypsin sequence and common protein
contaminant sequences. In the software algorithm, all modiﬁcations
listed in UniMod are searched simultaneously with the tolerances
speciﬁed as ±0.05 Da for peptides and MS/MS fragments (Shilov
et al., 2007). Protein Pilot automatically clusters the identiﬁed pro-
teins into protein groups sharing common peptides. Only protein
identiﬁcations with >99% conﬁdence were retained, resulting in FDR
<1% as calculated by decoy database search. For quantiﬁcation
analysis, peptide dimethylation at amino-termini or lysine residues
was speciﬁed to be the quantiﬁcation method. Only peptides of
unique sequences (not shared with other proteins) and free of
miscleavages or variable modiﬁcations contributed to protein ratio
calculation. Protein ratios and P-values based on at least two unique
peptide ratios were calculated by the software. In each replicate,
only proteins identiﬁed with above 99% conﬁdence and quantiﬁed
with at least two unique peptides are considered quantiﬁable pro-
teins. As we prepared two biological replicates with each processed
in triplicate for immunoprecipitation and LC-MS/MS analysis, pro-
teins that are quantiﬁable in at least two out of the three experiments
of each biological replicate were retained for comparative analysis.
The ultimate average ratios of individual proteins in the liver extracts
of wild-type mice vs. HDAC6 knockout mice (WT/KO) were derived
from four to six independent experiments, and P-values indicating
signiﬁcance of their differences from unity were calculated using
two-tail student’s t-tests.
Cell transfection and treatment
Cells were transfected with plasmids by using the polyethyleneimine
reagent (Sigma-Aldrich). After 24 h of transfection, cells were sub-
jected to immunoprecipitation or immunoﬂuorescence microscopy.
HDAC inhibitors were used at the following concentrations for 8 h
unless indicated otherwise: tubacin (5 μmol/L), TSA (5 μmol/L), and
NaB (10 mmol/L).
Immunoblotting and immunoprecipitation
Proteins were resolved by SDS-PAGE and transferred onto polyvi-
nylidene diﬂuoride membranes (Millipore). The membranes were
blocked with 5% fat-free milk in Tris-buffered saline containing 0.1%
Tween 20 and probed with primary antibodies and then horseradish
peroxidase-conjugated secondary antibodies. The target proteins
were visualized with enhanced chemiluminescence detection
reagent following the manufacturer’s instructions (Pierce Biotech-
nology). For immunoprecipitation, protein samples were incubated
with antibody-conjugated agarose beads overnight at 4°C. The
beads were washed extensively and subjected to immunoblotting.
Immunoﬂuorescence microscopy
Cells grown on glass coverslips were ﬁxed with 4% paraformalde-
hyde for 30 min at room temperature. Cells were then treated with
0.5% Triton X-100 in PBS for 20 min for permeabilization and
blocked with 2% bovine serum albumin in PBS. Cells were then
incubated in succession with the primary antibody and rhodamine-
conjugated secondary antibody followed by staining with DAPI for
3 min. For some experiments, cells were also stained with ﬂuores-
cein-phalloidin for the visualization of actin ﬁlaments. Coverslips
were mounted with 90% glycerol in PBS, and images were obtained
using an Axio Observer A1 ﬂuorescence microscope (Carl Zeiss Inc)
or a TCS SP5 confocal microscope (Leica).
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